Alnylam Pharmaceuticals
ALNY
#632
Rank
C$55.26 B
Marketcap
C$413.93
Share price
1.67%
Change (1 day)
-0.60%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: C$684.52 CAD on 2025-10-20

Lowest end of day price: C$5.50 CAD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2026

Annual Stock Price Performance

Year Performance
2026-26.53%
2025 70.21%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
C$208.39 2.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$62.26 1.82%๐Ÿ‡ซ๐Ÿ‡ท France
C$857.73 0.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$21.97 1.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.37 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.99-0.35%๐Ÿ‡บ๐Ÿ‡ธ USA
C$46.52 0.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$101.16-1.72%๐Ÿ‡บ๐Ÿ‡ธ USA